title: TRAMP prostate tumor growth is slowed by walnut diets through altered IGF-1 levels, energy pathways, and cholesterol metabolism.
abstract: Dietary changes could potentially reduce prostate cancer morbidity and mortality. Transgenic adenocarcinoma of the mouse prostate (TRAMP) prostate tumor responses to a 100 g of fat/kg diet (whole walnuts, walnut oil, and other oils; balanced for macronutrients, tocopherols [α-and γ]) for 18 weeks ad libitum were assessed. TRAMP mice (n=17 per group) were fed diets with 100 g fat from either whole walnuts (diet group WW), walnut-like fat (diet group WLF, oils blended to match walnut's fatty acid profile), or as walnut oil (diet group WO, pressed from the same walnuts as WW). Fasted plasma glucose was from tail vein blood, blood was obtained by cardiac puncture, and plasma stored frozen until analysis. Prostate (genitourinary intact [GUI]) was weighed and stored frozen at -80°C. Plasma triglyceride, lipoprotein cholesterol, plasma multianalyte levels (Myriad RBM Rat Metabolic MAP), prostate (GUI), tissue metabolites (Metabolon, Inc., Durham, NC, USA), and mRNA (by Illumina NGS) were determined. The prostate tumor size, plasma insulin-like growth factor-1 (IGF-1), high density lipoprotein, and total cholesterol all decreased significantly (P<.05) in both WW and WO compared to WLF. Both WW and WO versus WLF showed increased insulin sensitivity (Homeostasis Model Assessment [HOMA]), and tissue metabolomics found reduced glucose-6-phosphate, succinylcarnitine, and 4-hydroxybutyrate in these groups suggesting effects on cellular energy status. Tissue mRNA levels also showed changes suggestive of altered glucose metabolism with WW and WO diet groups having increased PCK1 and CIDEC mRNA expression, known for their roles in gluconeogenesis and increased insulin sensitivity, respectively. WW and WO group tissues also had increased MSMB mRNa a tumor suppressor and decreased COX-2 mRNA, both reported to inhibit prostate tumor growth. Walnuts reduced prostate tumor growth by affecting energy metabolism along with decreased plasma IGF-1 and cholesterol. These effects are not due to the walnut's N-3 fatty acids, but due to component(s) found in the walnut's fat component.
authors.affiliation: 1 Department of Physiology, College of Veterinary Medicine, Konkuk University , Seoul, South Korea .
authors.forename: Hyunsook
authors.initials: H
authors.lastname: Kim
authors.forename: Wallace
authors.initials: W
authors.lastname: Yokoyama
authors.forename: Paul Andrew
authors.initials: PA
authors.lastname: Davis
mesh_terms: D000230:Adenocarcinoma / Q000178:diet therapy* / Q000378:metabolism; D000818:Animals; D002784:Cholesterol / Q000097:blood; D004041:Dietary Fats / Q000032:analysis; D004734:Energy Metabolism; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D031324:Juglans / Q000737:chemistry; D008074:Lipoproteins / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010938:Plant Oils / Q000627:therapeutic use*; D011467:Prostate / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000178:diet therapy* / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D024505:Tocopherols / Q000627:therapeutic use
chemical_list: D004041:Dietary Fats; D008074:Lipoproteins; D010938:Plant Oils; D012333:RNA, Messenger; D007334:Insulin-Like Growth Factor I; D002784:Cholesterol; D024505:Tocopherols
keywords: chemoprevention; fat; insulin-like growth factor 1; prostate cancer; transgenic adenocarcinoma of the mouse prostate model; walnut; whole foods